关注
LUCA PINZI
标题
引用次数
引用次数
年份
Molecular docking: shifting paradigms in drug discovery
L Pinzi, G Rastelli
International journal of molecular sciences 20 (18), 4331, 2019
13772019
On the Integration of In Silico Drug Design Methods for Drug Repurposing
E March-Vila, L Pinzi, N Sturm, A Tinivella, O Engkvist, H Chen, G Rastelli
Frontiers in pharmacology 8, 298, 2017
1932017
Computational polypharmacology comes of age
G Rastelli, L Pinzi
Frontiers in pharmacology 6, 156476, 2015
662015
Hydroxamic acid derivatives: From synthetic strategies to medicinal chemistry applications
A Citarella, D Moi, L Pinzi, D Bonanni, G Rastelli
ACS omega 6 (34), 21843-21849, 2021
572021
Refinement and rescoring of virtual screening results
G Rastelli, L Pinzi
Frontiers in chemistry 7, 498, 2019
542019
Repositioning natural products in drug discovery
G Rastelli, F Pellati, L Pinzi, MC Gamberini
Molecules 25 (5), 1154, 2020
372020
Drug repurposing and polypharmacology to fight SARS-CoV-2 through inhibition of the main protease
L Pinzi, A Tinivella, F Caporuscio, G Rastelli
Frontiers in pharmacology 12, 636989, 2021
332021
Antifungal Activity and DNA Topoisomerase Inhibition of Hydrolysable Tannins from Punica granatum L.
V Brighenti, R Iseppi, L Pinzi, A Mincuzzi, A Ippolito, P Messi, SM Sanzani, ...
International Journal of Molecular Sciences 22 (8), 4175, 2021
302021
Design of dual inhibitors of histone deacetylase 6 and heat shock protein 90
L Pinzi, R Benedetti, L Altucci, G Rastelli
ACS omega 5 (20), 11473-11480, 2020
302020
Structure–Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFR
L Carlino, MS Christodoulou, V Restelli, F Caporuscio, F Foschi, ...
ChemMedChem 13 (24), 2627-2634, 2018
262018
Selection of protein conformations for structure-based polypharmacology studies
L Pinzi, F Caporuscio, G Rastelli
Drug Discovery Today 23 (11), 1889-1896, 2018
252018
In silico repositioning of cannabigerol as a novel inhibitor of the enoyl acyl carrier protein (ACP) reductase (INHA)
L Pinzi, C Lherbet, M Baltas, F Pellati, G Rastelli
Molecules 24 (14), 2567, 2019
232019
Identification of small-molecule EGFR allosteric inhibitors by high-throughput docking
F Caporuscio, A Tinivella, V Restelli, MS Semrau, L Pinzi, P Storici, ...
Future Medicinal Chemistry 10 (13), 1545-1553, 2018
212018
Heat shock protein 90 and serine/threonine kinase B-Raf inhibitors have overlapping chemical space
A Anighoro, L Pinzi, G Marverti, J Bajorath, G Rastelli
RSC advances 7 (49), 31069-31074, 2017
192017
Prediction of activity and selectivity profiles of human Carbonic Anhydrase inhibitors using machine learning classification models
A Tinivella, L Pinzi, G Rastelli
Journal of Cheminformatics 13, 1-15, 2021
172021
Promising non-cytotoxic monosubstituted chalcones to target monoamine oxidase-B
LG Iacovino, L Pinzi, G Facchetti, B Bortolini, MS Christodoulou, C Binda, ...
ACS Medicinal Chemistry Letters 12 (7), 1151-1158, 2021
172021
Identification of target associations for polypharmacology from analysis of crystallographic ligands of the Protein Data Bank
L Pinzi, G Rastelli
Journal of Chemical Information and Modeling 60 (1), 372-390, 2019
172019
LigAdvisor: a versatile and user-friendly web-platform for drug design
L Pinzi, A Tinivella, L Gagliardelli, D Beneventano, G Rastelli
Nucleic Acids Research 49 (W1), W326-W335, 2021
162021
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs)
P Linciano, R Benedetti, L Pinzi, F Russo, U Chianese, C Sorbi, L Altucci, ...
Bioorganic Chemistry 106, 104462, 2021
162021
Dual targeting strategies on histone deacetylase 6 (HDAC6) and heat shock protein 90 (Hsp90)
D Bonanni, A Citarella, D Moi, L Pinzi, E Bergamini, G Rastelli
Current Medicinal Chemistry 29 (9), 1474-1502, 2022
142022
系统目前无法执行此操作,请稍后再试。
文章 1–20